Butyrate Production

This marker assesses the genetic capacity of your gut ecosystem to produce Butyrate, the most important short-chain fatty acid (SCFA) for human health. Butyrate is the fuel that keeps your gut lining alive. A high capacity for bacterial production ensures a strong gut barrier, extinguishes systemic inflammation, and actively protects you against colorectal cancer and autoimmune diseases.

Human digestion is imperfect. We do not possess the enzymes to digest the fiber present in vegetables, legumes, and whole grains. When this fiber reaches the large intestine intact, it encounters a series of specialized bacteria. These bacteria ferment the fiber and produce compounds called Short-Chain Fatty Acids (SCFAs). Of all of them, butyrate is the "king".

Unlike other nutrients that you absorb into the blood to fuel your body, butyrate is consumed almost entirely on the spot, in the place where it is produced. It is the preferred and exclusive food for colonocytes (the cells that line the walls of your colon). It provides up to 70% of the energy these cells need to regenerate, respire, and keep the intestinal wall sealed and protected against invaders.

Bacterial butyrate production is one of the fundamental pillars of modern preventive medicine:

• Intestinal Barrier Sealing (Leaky Gut): When well-fed with butyrate, colon cells have enough energy to produce mucus and strongly maintain "Tight Junctions." This prevents toxins and bacteria from entering the bloodstream, curbing systemic inflammation at its source.
• Inflammation Suppression: Butyrate is a potent epigenetic agent (HDAC inhibitor). This means it has the ability to enter the nucleus of your immune cells and "turn off" genes that cause inflammation, while simultaneously stimulating the creation of T-regulatory cells (cells that prevent allergies and autoimmune diseases).
• Colorectal Cancer Prevention: While butyrate makes healthy colon cells grow and thrive, it has a paradoxical and lethal effect on cancer cells: it induces apoptosis (programmed cell suicide) in tumor cells that try to form in the intestine.
• Metabolism and Insulin Sensitivity: Butyrate that manages to enter circulation stimulates the release of hormones like GLP-1 and PYY, which increase the feeling of fullness and dramatically improve insulin sensitivity, helping to prevent Type 2 Diabetes.

The assessment of butyrogenic capacity is performed by Shotgun metagenomic sequencing, quantifying the overall genetic potential of the synthesis pathways for this short-chain fatty acid in the ecosystem. Our bioinformatic algorithm tracks and maps the abundance of terminal routes for butyrate synthesis from acetyl-CoA. We specifically quantify key gene families such as but/buk (butyrate kinase), ptb (phosphotransbutyrylase), and CoA transferases (atoA/atoD).

Taxonomically, the main butyrate producers are strict anaerobic bacteria belonging to the phylum Firmicutes, specifically grouped in clusters Clostridium IV and XIVa. Key "Keystone" species such as Faecalibacterium prausnitzii, Eubacterium rectale, species of the genus Roseburia and Clostridium butyricum stand out.

High capacity is a sign of a robust and anti-inflammatory ecosystem. It reflects adequate consumption of MACs (Microbiota-Accessible Carbohydrates) and excellent barrier function. Conversely, low capacity denotes a clinical alert of intestinal vulnerability ("colonic starvation"). It is commonly associated with low-fiber diets, chronic inflammation (Crohn's Disease, Colitis), or severe post-antibiotic dysbiosis. The strategy demands a gradual but firm increase in specific prebiotic fibers, especially Resistant Starch and Inulin, to stimulate the growth of primary producers, which can be temporarily accompanied by direct supplementation with butyrate salts (tributyrin) to "rescue" weakened colonocytes.